Doxorubicin FDA Link Generic

Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN.

Also Known As:

Adriamycin; Rubex; Doxorubicin Hydrochloride; Adriablastin; Adriablastine; Adriblastin; Adriblastina; Adriblastine; Adrimedac; DOXO-cell; Doxolem; Doxorubicin Hexal; Doxorubicin NC; Doxorubicina Ferrer Farm; Doxorubicina Funk; Doxorubicina Tedec; Doxorubicine Baxter; Doxotec; Farmiblastina; Myocet; Onkodox; Ribodoxo; Urokit Doxo-cell; DOXO cell; Hydrochloride, Doxorubicin; Urokit Doxo cell; 5,12-Naphthacenedione, 10- ((3- amino- 2,3,6- trideoxy- alpha- L- lyxo- hexopyranosyl)oxy)- 7,8,9,10- tetrahydro- 6,8,11- trihydroxy- 8- (hydroxyacetyl)- 1- methoxy- , (8S-cis)-

Pharmalogical Action Categories:

Antibiotics, Antineoplastic
Topoisomerase II Inhibitors

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Polycyclic Aromatic Hydrocarbons: 2020
        Naphthacenes
        Anthracyclines: 9423
        Daunorubicin: 2641
        Doxorubicin: 35390
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Naphthacenes
    - Anthracyclines: 9423
      - Daunorubicin: 2641
        Doxorubicin: 35390
Carbohydrates: 22023
- Glycosides: 2119
  - Aminoglycosides: 5131
    - Anthracyclines: 9423
      - Daunorubicin: 2641
        Doxorubicin: 35390

Reiko Tanigaki Selected Research

Reiko Tanigaki Research Topics

Disease

Drug/Important Bio-Agent (IBA)